Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-01, Stock:LLY, The news for the past five days is as follows:
2020-05-22: NEWS1: Better Buy: AbbVie vs. Eli Lilly.NEWS2: Medtronic (MDT) Q4 Earnings Miss Estimates, Revenues Beat.
2020-05-26: NEWS1: Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model.NEWS2: CanSino Biologics' Covid-19 Vaccine Shows Early Promise.NEWS3: Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2.NEWS4: Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2.NEWS5: Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies.NEWS6: Lilly, Junshi Biosciences to start human trials of COVID-19 antibodies.NEWS7: Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction.NEWS8: Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure.NEWS9: Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?.
2020-05-27: NEWS1: Sanofi's Dupixent Gets FDA Approval for Eczema in Children.NEWS2: Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio.NEWS3: Zacks.com featured highlights include: Eli Lilly and Company, Quidel, Everbridge and Sprouts Farmers Market.NEWS4: White House announces plan for Medicare enrollees to get insulin for $35 a month.NEWS5: Eli Lilly's COVID-19 therapy development partner AbCellera raises $105 million.NEWS6: Antibody drug tech firm AbCellera raises $105 million as it works on COVID-19.
2020-05-28: NEWS1: Lilly Receives U.S. FDA Approval of TAUVID™ (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease.NEWS2: U.S. FDA approves Eli Lilly's diagnostic agent for Alzheimer's disease.NEWS3: Thursday Morning Market Highlights.NEWS4: 3 Investing Facts About Required Minimum Distributions You Need to Know - May 28, 2020.
2020-05-29: NEWS1: FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid.NEWS2: Lilly Cleared by FDA to Market Alzheimer's Detection Drug.NEWS3: Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates,SNY to Sell Stake in REGN.NEWS4: Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates.NEWS5: Lilly gets FDA approval for Alzheimer's diagnostic agent.NEWS6: Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent.

Answer: Decrease